Our idea was born in the lab. We worked for many years with human samples. In our daily routine we realized that the quality of human samples in preanalytics remained a black box for us. We neither had automized nor standardized data to correspond with the technical quality of our laboratory analyzers. Thus, we decided this needs to change - for reliable diagnostics for labs, medical doctors and patients.

photo by Roche/Kern

The company

At S4DX we work together as a team of Software Developers, Molecular Biologists, Hardware Engineers, Physicists, Bio-Statisticians and many others to create a unique solution for preanalytics. Our diversity in academia, nationalities and experience creates solutions where others see only barriers.

The goal

Our goal is to enable a new quality standard for medical diagnostics and provide a full data-chain of custody for every human blood sample. Starting at the point of collection and directly integrating in the workflow of the lab.

Company story

2017
The need was realized in daily routine and idea was created by the four-founders
2018
January
Company registered
February
Investors Choice Award, Firecamp Up2B, STARTUP Mannheim and Heidelberg Startup Partners
June
Winning Startup at Techfest/ Hackathon TU Munich
July
Winner, best eHealth Solution in Europe, EIT-Health WildCard Challenge
October
WHO World Health Summit Finalist; Bill and Melinda Gates Foundation, Invited to the Grand Challenges Annual Meeting
2019
January
PlugNPlay Startup Creasphere "Digital Health Accelerator" Batch One Graduate
June
ACI Boston – accepted into the EIT Health Gold-Track Programme
November
Winner Digital Health Summit Munich 2019
2020
February
S4DX moves into new offices in München-Obersendling
March
Accepted into EU-EIC Accelerator as 3rd most innovative small-medium company in Europe (from 1852 applicants)
June
First customers in our Early Adopter Programme
June
Company graduates after being elected three consecutive times into the Gold-Track Programme
July
S4DX is ISO 9001 quality certified
2021
January
S4DX is accepted into the German Accelerator Life Sciences US
May
S4DX closes Series-A investment round and starts collaborating with Sarstedt as strategic partner
September
S4DX is named "Innovator of the year" in Digital Healthcare by the Handelsblatt and the FAU.
October
S4DX is ISO 27001 certified for its information security management systems
2022
January
S4DX Satellite App is launched globally on the Roche Cobas Pulse.

Management Team

We promote the power of individuals in our team and together we make the impossible of today possible - we shape the future of precision medicine and always focus on doing our best for patient`s care

  • CSO
    Dr. sc. nat.
    Yannick Timo Böge
    CSO
    Dr. sc. nat.
    Yannick Timo Böge

    PhD in Molecular Biology at the University Hospital in Zürich. Worked as Head of a Clinical Research Laboratory in Germany for international IVD- and MD clinical and technical studies; providing an excellent scientific and regulatory as well as customer understanding of the laboratory market.

  • CTO + CFO
    Dr. rer. nat. MBA
    Julia Flötotto
    CTO + CFO
    Dr. rer. nat. MBA
    Julia Flötotto

    PhD in Computer Science, MBA in Entrepreneurship; experience of more than 15 years in agile software development and leading software developers. First-hand start-up knowledge, coordinating all financial and entrepreneurial aspects.

  • CEO
    Dr. phil. MBA
    Hans Maria Heyn
    CEO
    Dr. phil. MBA
    Hans Maria Heyn

    PhD in Governance, MBA in Change-Management and M.Sc. in IVD- and MD regulatory affairs; worked more than ten years for a leading German Think Tank and headed the strategy development of a clinical research organisation. Responsible for business development and sales & marketing.

Board Member

  • Head of Board
    Chair of the Board
    Dr. Constanze Ulmer-Eilfort
    Head of Board
    Chair of the Board
    Dr. Constanze Ulmer-Eilfort

    Constanze Ulmer-Eilfort is an attorney-at-law, admitted in Germany and New York, specializing on intellectual property, with a strong focus on the Life Sciences industry, advising biotech and pharmaceutical companies on collaboration and licensing agreements. She has been a partner with Baker McKenzie for 30 years, and was Managing Partner of the German and Austrian offices from 2012 to 2017 and member of the Global Executive Committee from 2017 to 2021. She was Chair of the Global Policy Committee, Chair of the Global Financial Committee and Chair of the Global Diversity and Inclusion Committee, and Chair of the EMEA Region. Constanze Ulmer-Eilfort is living in Munich and Rome.

  • Dr. Kurt Hoeller
    Dr. Kurt Hoeller

    Director of Business creation and member of the Executive Team of EIT Health, Kurt is also leading the Health accelerator, and acting as Co-Managing Director of EIT Health Services and Investment GmbH. Previously, Kurt has founded and directed the Central Institute of Healthcare Engineering at FAU, as well as several spin-offs and companies, being currently vice-chairman of the supervisory board of ESTW AG, a company with nearly € 200M revenue and 500+ employees. Kurt holds a Doctorate from FAU involving TU Munich and Johns Hopkins University, USA, and an MBA from THD involving Santa Clara University in Silicon Valley.

  • Dr. Ursula Redeker
    Dr. Ursula Redeker

    Dr. Ursula Redeker is former Spokesperson of the Executive Board of Roche Diagnostics GmbH and former Managing Director of Roche Deutschland Holding GmbH. Senior executive in pharmaceutical and diagnostics industry with more than 25 years of experience (biotech and global corporations) and more than 15 years in senior leadership roles. Strong strategic leader with track record in leading continuous change and successful focus on finding and developing best talent

  • Rainer Schuster
    Rainer Schuster

    Member of the Executive Board Sales / R&D SARSTEDT AG & CO. KG

  • Dr. Valentin Piëch
    Dr. Valentin Piëch

    Valentin Piëch is a Managing Director at Zurich based life sciences venture capital firm VP Venture Partners and has a background in venture capital, science, and technology. Prior to founding VP Venture Partners, he was Investment Director at the VC firm BioMedPartners, and previously worked at Nextech Invest, a VC focusing on oncology. In addition, he is a private investor in a number of startup and growth companies. Valentin holds a PhD in Neuroscience from the Rockefeller University, a Master degree in Cognitive and Neural Systems from Boston University and a Master Degree in Mechanical and Process Engineering from the Federal Institute of Technology in Zurich (ETH).

  • European Investment Bank

Company values

Our success is based on our shared values and goals. In our daily work, we are guided by fairness, honesty, and mutual trust. Satisfied customers, motivated employees and doing good for the society and environment is no contradiction for us.

The outstanding performance of Smart4Diagnostics is only possible as a team. As an employer, we offer excellent job security and payment above start-up average. Through innovative training measures, we promote the personal and professional competence of all employees.

We expect our management to be role models in every aspect. Communication between management and employees is always characterized by courtesy, respect, and trust.

Social responsibility is part of our DNA. We are an inclusive start-up not only in words but in our daily work. We stand for a sustainable economy, live equal rights and reject discrimination, no matter what kind. We are convinced that great people form a great company.

Want to work with us?